Table 5.
Comparison between affected and unaffected group.
| Genotype | Affected case | Unaffected case | Odds ratio | 95% CI | P-value | Adjusted |
|---|---|---|---|---|---|---|
| BRCA1+ | ||||||
| 2R/2R | 45 | 16 | 0.9299 | 0.46–1.96 | 0.8637 | 0.9422 |
| 2R/1R | 87 | 26 | 1.265 | 0.66–2.42 | 0.5403 | 1 |
| 1R/1R | 32 | 13 | 0.7906 | 0.37–1.79 | 0.5664 | 1 |
| 1R/0R | 0 | 1 | 0 | 0–64.08 | 0.2522 | 1 |
| BRCA2+ | ||||||
| 2R/2R | 17 | 10 | 0.769 | 0.27–2.26 | 0.6281 | 0.9422 |
| 2R/1R | 39 | 12 | 1.8417 | 0.70–4.91 | 0.1904 | 1 |
| 1R/1R | 13 | 4 | 1.3929 | 0.38–6.45 | 0.7707 | 1 |
| 1R/0R | 0 | 2 | 0 | 0–1.44 | 0.0854 | 1 |
| BRCAx | ||||||
| 2R/2R | 20 | 3 | 0.77 | 0.19–3.19 | 0.7118 | 0.9350 |
| 2R/1R | 41 | 6 | 0.71 | 0.20–2.50 | 0.5951 | 1 |
| 1R/1R | 18 | 1 | 2.54 | 0.30–21.12 | 0.6850 | 1 |
| 1R/0R | 7 | 0 | Infinity | 0.23–infinity | 1 | 1 |